RIPK3 in keratinocytes facilitates psoriatic inflammation by promoting cytokine and chemokine production, independent of the induction of necroptosis. Control of RIPK3 activation may be a novel therapeutic target for psoriasis.
http://ift.tt/2mupt8X
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου